Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...

Non-Small Cell Lung Cancer Market grows as immunotherapy approvals by Merck & Bristol-Myers reshape global treatment pathways. Anurag Tiwari Orion Market Research Pvt Ltd +91 91798 28694 email us here ...

Corticosteroids are commonly prescribed to alleviate cancer-related symptoms in patients with non-small cell lung cancer, ...

Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...

AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ...

Nearly a quarter of all newly diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

Research highlights improved lung cancer biomarker testing in North America, though delays, costs, and limited satisfaction persist despite clinician awareness.